Micro-dosing Indocyanine Green (ICG) in Children
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
AgeUp to 18
SponsorGreat Ormond Street Hospital for Children NHS Foundation Trust
About this trial
The goal of this cohort study is to identify the lowest dose of Indocyanine Green (ICG) that achieves satisfactory intra-operative fluorescence for the assessment of gastrointestinal or genitourinary tract perfusion in children.
Eligibility criteria
Qualifiers
Children aged ≤18 years of age
Elective surgery including gastrointestinal or genitourinary tract perfusion assessment
Disqualifiers
Renal and liver dysfunction
Active infection
Coagulopathy
Complex congenital heart defect
Trial design
Treatments tested in this trial
- Indocyanine Green (ICG)
Treatment groups
90 Participants
are divided into 1 treatment groupLocations
1Great Ormond Street Hospital for ChildrenWC1N 3JH, London United Kingdom
Sponsors and collaborators
Great Ormond Street Hospital for Children NHS Foundation Trust
Lead sponsor
Source ClinicalTrials.gov